Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.040 | 2.040 | 0.000 |
Shares | 87.100 | 87.100 | 0.000 |
Other | 10.860 | 10.860 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.309 | 23.931 |
Price to Book | 9.339 | 4.517 |
Price to Sales | 4.870 | 3.291 |
Price to Cash Flow | 21.794 | 15.856 |
Dividend Yield | 1.451 | 1.239 |
5 Years Earnings Growth | 9.410 | 12.450 |
Name | Net % | Category Average |
---|---|---|
Consumer Defensive | 33.820 | 7.948 |
Healthcare | 32.370 | 16.432 |
Consumer Cyclical | 10.680 | 12.466 |
Technology | 10.050 | 26.715 |
Financial Services | 6.760 | 13.504 |
Industrials | 6.330 | 11.862 |
Number of long holdings: 25
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk A/S Class B | DK0060534915 | 5.14 | - | - | |
L'Oreal | FR0000120321 | 5.06 | 455.60 | +0.77% | |
Microsoft | US5949181045 | 4.79 | 422.64 | +1.58% | |
Church&Dwight | US1713401024 | 4.77 | 107.50 | -0.56% | |
McCormick&Co | US5797802064 | 4.70 | 67.64 | -1.79% | |
J&J | US4781601046 | 4.29 | 146.69 | -0.75% | |
P&G | US7427181091 | 4.21 | 165.53 | -0.89% | |
Visa A | US92826C8394 | 4.09 | 274.09 | +0.61% | |
Stryker | US8636671013 | 4.07 | 345.67 | +1.07% | |
ADP | US0530151036 | 4.06 | 244.50 | -0.48% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 15.22B | 7.14 | 5.85 | 15.68 | ||
Fundsmith Equity I Inc | 4.56B | 7.14 | 5.85 | 15.68 | ||
Fundsmith Equity R Acc | 599.13M | 6.92 | 5.21 | 14.98 | ||
Fundsmith Equity R Inc | 17.38M | 6.92 | 5.21 | 14.97 | ||
Fundsmith Equity T Acc | 4.14B | 7.10 | 5.74 | 15.57 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review